SANTARUS $22.28

up +0.76


18/6/2013 04:18 PM  |  NASDAQ : SNTS  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Get Trend Analysis Icon Get SNTS Trend Analysis - it has outperformed the S&P 500 by 197%

Partner Headlines

  1. Santarus, Inc. (SNTS) Sr. VP, CFO, Sec'y, Treas Debra P Crawford ...

    GuruFocus

  2. Santarus, Inc. (SNTS) President & CEO Gerald T Proehl sells 86,601 ...

    GuruFocus

  3. Santarus rises as FDA OKs drug

    Investors Business Daily

  4. Santarus Wins Drug Approval, Offers Bullish Guidance

    Investors Business Daily

  5. Santarus Wins Drug Approval, Offers Bullish Guidance

    Investors Business Daily

  6. Benzinga's Volume Movers

    Benzinga

  7. Mid-Morning Market Update: Dell Continues to Rise While Lulu Lemon ...

    Benzinga

  8. Santarus Stock Pops To 8-Year High On Drug Approval

    Investors Business Daily

  9. Benzinga's Top Pre-Market Gainers

    Benzinga

  10. FDA Approves Santarus' UCERIS for Induction of Remission in ...

    Benzinga

  11. Santarus Received Paragraph IV Certification Notice from Mylan, ...

    Benzinga

  12. Santarus, VeroScience Announce Publication of New CYCLOSET ...

    Benzinga

  13. A Peek Into The Market Before The Trading Starts

    Benzinga

  14. Santarus, Pharming Announce Phase III Results for RUCONEST in ...

    Benzinga

  15. Santarus Announces Publication of Results from UCERIS Pivotal ...

    Benzinga

  16. Santarus Reports Statistical;y Phase 3 Results on Rifamycin

    Benzinga

  17. UPDATE: Piper Jaffray Upgrades Santarus to Overweight on Cash ...

    Benzinga

  18. Santarus Announces Appellate Court Reversal in Part of Zegerid ...

    Benzinga

  19. Santarus Inc. Reports Operating Results (10-Q)

    GuruFocus

  20. Santarus Increases Revolving Line of Credit to $35 Million and ...

    at Benzinga

  21. From Earlier: Santarus Begins Promoting Cholesterol-Lowering ...

    at Benzinga

  22. End-of-Day Market Summary for December 20, 2011

    at Benzinga

  23. Santarus Submits New Drug Application to FDA for UCERIS Tablets

    at Benzinga

  24. Santarus and Pharming Announce Oral Presentations of Retrospective ...

    at Benzinga
People viewing SNTS also viewed: , , , , , ,
Marketplace
Trading Center